Fennec Pharmaceuticals Inc. (FRA:RV41)

Fennec Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.95	26.63	13.27	23.77	21.1	30.34
Cash & Short-Term Investments	21.95	26.63	13.27	23.77	21.1	30.34
Cash Growth	-45.57%	100.72%	-44.19%	12.67%	-30.46%	122.30%
Receivables	19.34	12.88	8.81	1.55	-	-
Inventory	2.48	1.06	2.16	0.58	-	-
Prepaid Expenses	1.4	3.08	2.58	0.77	1.03	0.8
Other Current Assets	0.9	0.47	0.04	0.06	0.25	0.28
Total Current Assets	46.06	44.12	26.86	26.73	22.39	31.42
Long-Term Deferred Charges	0.74	0.82	0.01	0.21	0.03	-
Total Assets	49.26	44.95	26.86	26.94	22.41	31.42
Accounts Payable	5.87	3.24	3.78	2.39	0.78	1.57
Accrued Expenses	3.7	3.43	3.75	2.22	0.88	0.78
Current Portion of Leases	-	0	0.02	-	-	-
Current Unearned Revenue	0.25	0.25	-	-	-	-
Total Current Liabilities	9.82	6.92	7.55	4.61	1.65	2.35
Long-Term Debt	19.38	19.34	30.93	24.9	4.99	-
Long-Term Unearned Revenue	24.56	24.56	0	-	-	-
Total Liabilities	53.75	50.82	38.49	29.51	6.64	2.35
Common Stock	147.65	145.61	144.31	142.59	140.8	140.73
Additional Paid-In Capital	71.25	66.96	62.07	56.8	53.21	49.23
Retained Earnings	-224.64	-219.68	-219.25	-203.2	-179.49	-162.14
Comprehensive Income & Other	1.24	1.24	1.24	1.24	1.24	1.24
Shareholders' Equity	-4.49	-5.87	-11.62	-2.57	15.77	29.07
Total Liabilities & Equity	49.26	44.95	26.86	26.94	22.41	31.42
Total Debt	19.38	19.34	30.95	24.9	4.99	-
Net Cash (Debt)	2.57	7.29	-17.68	-1.13	16.11	30.34
Net Cash Growth	-68.72%	-	-	-	-46.90%	122.30%
Net Cash Per Share	0.09	0.27	-0.67	-0.04	0.62	1.28
Filing Date Shares Outstanding	28.12	27.59	27.1	26.41	26.01	26
Total Common Shares Outstanding	28.06	27.53	27.03	26.36	26.01	26
Working Capital	36.25	37.21	19.31	22.12	20.73	29.07
Book Value Per Share	-0.16	-0.21	-0.43	-0.10	0.61	1.12
Tangible Book Value	-4.49	-5.87	-11.62	-2.57	15.77	29.07
Tangible Book Value Per Share	-0.16	-0.21	-0.43	-0.10	0.61	1.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.